Results 101 to 110 of about 1,026 (135)

From mechanism to targeted therapy: Advances in histone lactylation-driven cancer progression (Review). [PDF]

Oncol Lett
Jia Z, Lu S, Wang Z, Ge P.
europepmc   +1 more source

Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer. [PDF]

World J Surg Oncol
Ma Y, Lin G, Wang K, Liu Z, Shao Y, Yu W, Zhao X, Yu D, Zhan F, Wang X, Duan S, Duan K.   +11 more
europepmc   +1 more source

Enter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease. [PDF]

F1000Res
Altieri A, Visser GV, Buechler MB.
europepmc   +1 more source

Expression and role of CTHRC1 in inflammatory bowel disease in children. [PDF]

Cytotechnology
Tang H, Gao X, Wu Z, Chen J, Chen L, Du X.   +5 more
europepmc   +1 more source

Cancer-associated fibroblasts as a critical driver in tumor metastasis: The mechanisms and future perspectives. [PDF]

iScience
Ding L, Li Z, Yue J, Qiu L, Tian Z, Zhang H.   +5 more
europepmc   +1 more source

Mechanistic study of CTHRC1 in promoting Wilms' tumor progression by regulating M2-type tumor-associated macrophages polarization. [PDF]

J Transl Med
Zhuo Y, Feng X, Zhang W, Du J, Sun X, Luo X, Wang W, Jiang H, Gu H.   +8 more
europepmc   +1 more source

EMP1 + hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis. [PDF]

J Transl Med
You J, Huang Y, Jiang C, Xiao J, Zhang J, Liu Y, Sui X, Zhang Y, Yao J, Lu T.   +9 more
europepmc   +1 more source

Effect of a chondroitin sulfate chain linked to the bikunin core peptide on gene expression in lipopolysaccharide-treated uterine cervical fibroblasts. [PDF]

Biochem Biophys Rep
Kurotaki S, Kakizaki I, Tanaka K, Tsushima R, Suto S, Tanaka S, Kodama T, Ito A, Takahashi R, Yokoyama Y.   +9 more
europepmc   +1 more source

WTAP promotes laryngeal carcinoma cell progression by posttranscriptional activation of CTHRC1 in an m6A-YTHDF1-dependent way. [PDF]

Cytotechnology
Feng L, Wang Q, Zang R, Zhang M.
europepmc   +1 more source